Skip to main content

Bristol Myers Squibb looking for Patient Safety Manager - B.Pharm, M.Pharm or Pharm.D Apply

B.Pharm, M.Pharm or Pharm.D or Medical Professional. working in Regulatory, Clinical Operations or Medical Affairs, Pharmacovigilance.
Work in QA, QC, Production at Biological E. Limited - M.Pharm, B.Pharm, MSc Apply
Msc (Life science) / B. Pharmacy / Diploma, M. Tech Biotechnology. Production - Bulk Manufacturing Drug Substance / Antigens , Production Formulations Injectables, Quality Control Biologics / Vaccines, QA
Interview for M.Pharm, B.Pharm, M.Sc in Production Department at Aculife Healthcare
Sciences or pharmacy graduates M.Sc. / B.Pharm. / M.Pharm. in parenteral manufacturing
ICON plc Hiring PV Associate - B.Pharm, Degree in Life Sciences Apply
Bachelors degree in life sciences, pharmacy. process safety events pre-marketing, post-marketing, medical device and drug and/or other medically related information
Mepro Pharmaceuticals Hiring M.Pharm, B.Pharm in Regulatory Affairs
B. Pharma / M.Pharma. Review and submission of injectable product dossiers for TGA and Europe in CTD, ACTD formats.
Hiring for R&D Synthesis, AMD, ARDL Department at FDC India
M.Sc. in Chemistry. To modify the process or method of preperation for betterment. A leading pharmaceutical company is expanding its team
CORONA Remedies require Research Associate
Should have exposure in AMV, Routine analysis and Stability studies and should have the exposure in set-up
Biocon Foundation in Partnership with NCBS and BeST Cluster Launches BioWISE Program – to Empower Women in STEM
Biocon Foundation, the Corporate Social Responsibility arm of Biocon Group in collaboration with The Bengaluru Science and Technology (BeST) Cluster, and National Centre for Biological Sciences (NCBS) today announced the launch of first-of-its-kind program BioWISE – Women in STEM Empowered, aimed at disadvantaged science students from tier 2 and 3 universities across Karnataka, to build a career in life sciences.
Zydus receives EIR from USFDA for Dabhasa API manufacturing facility
Zydus Lifesciences has received the Establishment Inspection Report from the United States Food and Drug Administration for its Active Pharmaceutical Ingredient manufacturing facility located at Dabhasa, near Vadodara, Gujarat.
SGLT2 Inhibitors linked to reduced risk of Atrial Fibrillation in type 2 Diabetes
A new study published in the journal Diabetes, Obesity and Metabolism has found that sodium-glucose co-transporter-2 (SGLT2) inhibitors are associated with a reduced incidence of atrial fibrillation in patients with type 2 diabetes mellitus.